Literature DB >> 10728950

Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome.

R H Ali1, W Zareba, A J Moss, P J Schwartz, J Benhorin, G M Vincent, E H Locati, S Priori, C Napolitano, J A Towbin, W J Hall, J L Robinson, M L Andrews, L Zhang, K Timothy, A Medina.   

Abstract

In patients with the long QT syndrome (LQTS), the occurrence of cardiac events (syncope or cardiac arrest) is frequently associated with acute arousal caused by exercise, swimming, emotion, or noise. However, cardiac events may also occur during sleep or with ordinary daily activities. The purpose of this study was to determine whether there are differential clinical, electrocardiographic, and genetic features among LQTS patients who experienced cardiac events with and without acute arousal. We identified 1,325 patients with cardiac events from the International LQTS Registry. Based on the precipitating conditions of the first event, 427 patients were classified as arousal, 345 as nonarousal, and the remaining 553 were unknown (not classifiable). Gene linkage was known in 78 of the 772 patients with classifiable first events. The age at first cardiac event was significantly younger in the arousal than the nonarousal group (11.7 vs. 15.5 years, respectively; p<0.001). The arousal-type patients had a higher rate of subsequent cardiac events during follow-up after the index event than the nonarousal-type patients (p = 0.02). Arousal-related cardiac events occurred in 85% of LQT1, 67% of LQT2, and 33% of LQT3 patients (p = 0.008). This study provides evidence that the genotype is an important determinant of the LQTS phenotype in terms of arousal and nonarousal-related cardiac events.

Entities:  

Mesh:

Year:  2000        PMID: 10728950     DOI: 10.1016/s0002-9149(99)90772-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  Variable expression of long QT syndrome among gene carriers from families with five different HERG mutations.

Authors:  Jesaia Benhorin; Arthur J Moss; Matthew Bak; Wojciech Zareba; Elizabeth S Kaufman; Batsheva Kerem; Jeffrey A Towbin; Silvia Priori; Robert S Kass; Bernard Attali; Arthur M Brown; Eckhard Ficker
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-01       Impact factor: 1.468

2.  Arrhythmia mechanisms in the new millennium.

Authors:  R Lazzara
Journal:  J Interv Card Electrophysiol       Date:  2001-06       Impact factor: 1.900

Review 3.  Modulation of transmural repolarization.

Authors:  Charles Antzelevitch
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 4.  Drug-induced spatial dispersion of repolarization.

Authors:  Charles Antzelevitch
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

5.  Heart rate variability in patients with congenital long QT syndrome.

Authors:  J S Perkiömäki; W Zareba; J P Couderc; A J Moss
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

6.  Cardiac Arrhythmia: In vivo screening in the zebrafish to overcome complexity in drug discovery.

Authors:  Calum A Macrae
Journal:  Expert Opin Drug Discov       Date:  2010-07       Impact factor: 6.098

Review 7.  Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes.

Authors:  Charles Antzelevitch
Journal:  Europace       Date:  2007-09       Impact factor: 5.214

Review 8.  Autonomic aspects of arrhythmogenesis: the enduring and the new.

Authors:  Richard L Verrier; Charles Antzelevitch
Journal:  Curr Opin Cardiol       Date:  2004-01       Impact factor: 2.161

Review 9.  Cardiac repolarization. The long and short of it.

Authors:  Charles Antzelevitch
Journal:  Europace       Date:  2005-09       Impact factor: 5.214

Review 10.  Sympathetic nervous system activity and ventricular tachyarrhythmias: recent advances.

Authors:  Kelley P Anderson
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-01       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.